Occlusion Devices Market

Product Launches and Market Expansions are the Key Growth Strategies Adopted by Leading Market Players in the Global Occlusion Devices Market

The global occlusion devices market is projected to reach USD 3.55 Billion by 2023 from 2.74 Billion in 2018, at a CAGR of 5.3%. Factors such as the growth in target patient population, technological advancements, favorable reimbursement scenario for minimally invasive surgeries, and the availability of clinical evidence for the safety and efficacy of occlusion procedures are driving the growth of the occlusion devices market. However, procedural limitations associated with CTO treatments and stringent regulatory frameworks for product commercialization are expected to limit the optimal adoption of occlusion devices during the forecast period.

Analysis of the market developments between 2015 and 2018 reveals that several growth strategies such as product launches; expansions; acquisitions; and collaborations, partnerships, and agreements were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the occlusion devices market. Among these business strategies, product launches and market expansions were the most widely adopted growth strategies by players in the market.

Boston Scientific (US) held a significant position in the occlusion devices market in 2017. The company has a strong geographic presence across the US, Canada, France, Singapore, Costa Rica, Ireland, the Netherlands, Japan, China, and Turkey. The company mainly focuses on product launches and strategic collaborations to strengthen the minimally invasive product portfolio as well as to expand its customer base in the occlusion devices market. For instance, in November 2015, the company commercialized its Angiojet Zelante DVT thrombectomy catheter. Furthermore, in March 2016, Boston Scientific collaborated with Mayo Clinic (US) to develop interventional medical devices including occlusion devices.

Medtronic (Ireland) was one of the leading players in the occlusion devices market in 2017. The company has a strong foothold in the occlusion devices market with a significant product portfolio. To strengthen its current position and to gain a larger share in the occlusion devices market, the company aggressively focuses on inorganic business growth strategies such as market expansions and strategic acquisitions. The company established its cross-disciplinary clinical training and R&D center-Chengdu Innovation Center (Singapore); a training and research facility-Covidien Center of Innovation Brazil (CCI) (Brazil); and an R&D, training, and education center-Covidien Center of Innovation Korea (CCI Korea) (South Korea) to strengthen its R&D capabilities in emerging markets. Also, the company commercialized its Total Across Crossing Support Catheter and Apollo Onyx Delivery Catheter in order to strengthen its presence in the occlusion devices market.

Related Reports:

Occlusion Devices Market by Product (Occlusion Balloon, Stent Retriever, Suction Device, Coil Embolization, Liquid Embolics), Application (Cardiology, Neurology, Peripheral Vascular, Urology, Oncology, Gyno), End User - Global Forecast to 2023

Contact:
Mr. Rohan
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Report Code
MD 6193
Published ON
Apr, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Occlusion Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved